Skip to content

Dexcowin Global, Inc.

Country not established

Devices
1

What Dexcowin Global, Inc. makes

Dexcowin Global, Inc. manufactures the Cocoon Solo (DX-7020s), a medical device designed for neonatal resuscitation and respiratory support in newborns.

The Cocoon Solo is classified as a Class II device under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Cocoon Solo (DX-7020s) Ref K250687

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Dexcowin Global, Inc. have in the registry?

The registry currently lists 1 device for Dexcowin Global, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Dexcowin Global, Inc.'s devices?

Among its 1 most recently registered device, Dexcowin Global, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Dexcowin Global, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Dexcowin Global, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Dexcowin Global, Inc. in the registry?

The most recently registered devices listed for Dexcowin Global, Inc. include Cocoon Solo (DX-7020s).

Generated automatically from registry data and not verified by a human reviewer.